Markets.com Logo

CARA

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    17.5264$
  • Previous Close
    18.3429$
  • 52 Week Change
    21.86$
  • Day Range
    -0.82$
  • 52 Week High/Low
    8.1252$ - 29.9808$
  • Dividend Per Share
    --
  • Market cap
    8 111 K$
  • EPS
    -1.6799
  • Beta
    0.413
  • Volume
    --

About

CARA.US represents the common stock of Cara Therapeutics, Inc. This biopharmaceutical company focuses on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors. Cara Therapeutics is a publicly traded company, and its stock is listed on the Nasdaq Stock Market under the ticker symbol CARA. Investors can trade shares of Cara Therapeutics through various brokerage accounts.

US CPI August: Inflation Outlook and Fed's Next Move

Sophia Claire|--

ECB Interest Rate Outlook: Analysis from Multiple Perspectives

Sophia Claire|--

Trump's Foreign Policy Tested: Israeli Strike & Russian Drone Challenge Authority

Sophia Claire|--
Nvidia Stock Jumps 4%: Why Is Nvidia (NVDA) Stock Soaring Today?

Nvidia Stock Jumps 4%: Why Is Nvidia (NVDA) Stock Soaring Today?

Ghko B|--
SMCI Stock Is Trading 2.3% Higher: What’s Next for Super Micro Stock?

SMCI Stock Is Trading 2.3% Higher: What’s Next for Super Micro Stock?

Frances Wang|--
Gold Price Prediction: Will XAU/USD Hit $4,000 in 2025?

Gold Price Prediction: Will XAU/USD Hit $4,000 in 2025?

Ghko B|--

Fed Rate Cut Looming: Is It Time to Rethink the 2% Inflation Target?

Emma Rose|--

Factors

Cara Therapeutics' stock price, CARA.US, is influenced by several factors: Clinical Trial Results: Positive clinical trial outcomes for Cara's pipeline drugs, especially Korsuva, typically drive the stock price up. Conversely, failures or setbacks depress it. Regulatory Decisions: FDA approvals or rejections significantly impact investor sentiment and the stock's value. Approvals lead to potential revenue streams. Market Conditions: Overall market trends, especially in the biotechnology sector, influence CARA.US. Bull markets boost, bear markets depress. Competition: The emergence of competing pain management drugs affects Korsuva's market potential and CARA's valuation. Financial Performance: Cara's cash burn rate, revenue (primarily from collaborations), and overall financial health play a role in investor confidence. Partnerships/Collaborations: Deals with pharmaceutical companies for development or commercialization can positively impact the stock price. Analyst Ratings: Upgrades or downgrades from financial analysts can influence investor behavior and price movements.

People Also Watch

Latest news

Dalio: Gold as a Hedge Against Mounting Debt Risks

Emma Rose|--

Switzerland Proposes US Gold Refinery to Reduce Tariffs

Ava Grace|--

NATO and EU on Edge After Russian Drone Enters Poland: A Critical Test

Noah Lee|--

Latest Education Articles

Commodity CFD Trading for Beginners: CFDs on Gold (XAU/USD)

Commodity CFD Trading for Beginners: CFDs on Gold (XAU/USD)

Frances Wang|--
Forex Market Today: AUD/USD Jumps, How to Trade AUD/USD CFD?

Forex Market Today: AUD/USD Jumps, How to Trade AUD/USD CFD?

Frances Wang|--
Oracle Stock Is Rising: How to Trade Oracle Stock (ORCL) CFD?

Oracle Stock Is Rising: How to Trade Oracle Stock (ORCL) CFD?

Frances Wang|--